AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Nov 23 | BuyUK£203,312 | Michel Demare | Individual | 2,000 | UK£101.70 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 431,947 | 0.0279% |
Public Companies | 737,191 | 0.0476% |
Private Companies | 2,380,526 | 0.154% |
State or Government | 2,733,890 | 0.176% |
General Public | 209,839,512 | 13.5% |
Institutions | 1,334,133,236 | 86.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
155,435,297 | UK£19.2b | 17.6% | 1.22% | |||
137,588,369 | UK£17.0b | 2.04% | 0.37% | |||
98,340,427 | UK£12.2b | 26% | 2.38% | |||
71,452,666 | UK£8.8b | 1.95% | 0.18% | |||
51,587,810 | UK£6.4b | 0% | 11.46% | |||
35,415,803 | UK£4.4b | -0.34% | 0.46% | |||
31,039,283 | UK£3.8b | -42.1% | 0.45% | |||
29,472,139 | UK£3.6b | -5.92% | 0.29% | |||
27,627,154 | UK£3.4b | 3.52% | 0.18% | |||
26,023,128 | UK£3.2b | -2.03% | 0.8% | |||
21,472,587 | UK£2.7b | -0.1% | 2.38% | |||
18,851,059 | UK£2.3b | -4.07% | 0.36% | |||
18,797,637 | UK£2.3b | 11.3% | 0.62% | |||
15,863,398 | UK£2.0b | -12.1% | 1.98% | |||
15,739,513 | UK£1.9b | -5.13% | 1.11% | |||
12,631,034 | UK£1.6b | 0.04% | 0.24% | |||
11,887,908 | UK£1.5b | -3.23% | 2.6% | |||
11,053,280 | UK£1.4b | -18.8% | 1.14% | |||
10,994,983 | UK£1.4b | -3.44% | 2.12% | |||
10,665,114 | UK£1.3b | 0.09% | 0.27% | |||
10,536,060 | UK£1.3b | -2.83% | 1.25% | |||
10,517,154 | UK£1.3b | 26.3% | 0.45% | |||
10,452,907 | UK£1.3b | 23% | 2.58% | |||
9,116,175 | UK£1.1b | -13.5% | 0.34% | |||
9,087,870 | UK£1.1b | 84.5% | 0.52% |